Global Uveitis Treatment Market Set for Rapid Growth, to reach Value around USD 474.34 Million by 2025

Zion Market Research has published a new report titled “Uveitis Treatment Market by Treatment type (corticosteroids, immunosuppressant, monoclonal antibodies, cycloplegic agents, antibiotics, antivirals, antifungal, and analgesics), Disease type (anterior uveitis, posterior uveitis, intermediate uveitis and panuveitis), Distribution Channel (hospitals, ophthalmology clinics, ambulatory surgical centers, and others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2025”. According to the report, global demand for Uveitis Treatment market was valued at approximately USD 474.34 million in 2018, and is expected to generate revenue of around USD 727.75 million by end of 2025, growing at a CAGR of around 6.35% between 2019 and 2025.

Browse the full “Uveitis Treatment Market: by Treatment type (corticosteroids, immunosuppressant, monoclonal antibodies, cycloplegic agents, antibiotics, antivirals, antifungal, and analgesics), Disease type (anterior uveitis, posterior uveitis, intermediate uveitis and panuveitis), Distribution Channel (hospitals, ophthalmology clinics, ambulatory surgical centers, and others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025” Report at https://www.zionmarketresearch.com/report/uveitis-treatment-market

Uveitis is the middle layer of the eye inflammation called the uvea. It may be caused by both infectious and non-infectious causes. The uvea supplies oxygen to the retina. The retina is the light-sensitive part of the eye that focuses on the brain and sends the images. It is usually red due to its uvea blood supply. Normally, uveitis is not serious. If not treated early, more severe cases can result in loss of vision. The following symptoms can occur in one or both eyes: extreme eye redness, discomfort, dark floating spots in your vision, floaters, light sensitivity, and blurred vision. The cause of uveitis is often unclear and often occurs in otherwise well-being individuals. It can sometimes be related to another disease such as an autoimmune disorder or a virus or bacterial infection.

New developments in drug formulations and treatment modalities are continuing, for instance, a major breakthrough was Humira's approval for uveitis care. As a consequence, some of the driving factors are expected to be factors such as increased geriatric population, increased incidence of disease, and new product developments Redness of the eyes, blurring of the vision, small size of the pupil, and sensitivity to light may be symptoms of anterior uveitis that may result in permanent blindness if not treated. Increasing incidence of optical infections in conjunction with increased knowledge of various treatments is likely to help market growth over the forecast period. Some of the industry's key factors are high insurance costs, increased disposable income, and favorable government regulations.

The market for Uveitis Treatment is segmented based on treatment type, disease type, distribution channel, and region. 
Based on product, the market is segmented into corticosteroids, immunosuppressant, monoclonal antibodies, cycloplegic agents, antibiotics, antivirals, antifungal, and analgesics. Corticosteroids dominated the anterior uveitis treatment market in 2018, as they are first-line treatments for anterior uveitis. They are both used as eye drops as well as routine treatment. Corticosteroids are also used in eye implants in the treatment of continued release. 

Based on disease type, the market is segmented into anterior uveitis, posterior uveitis, intermediate uveitis and panuveitis. Due to the high incidence of adult and youth disease, anterior uveitis led the uveitis treatment market in 2018. Increasing work in this area also highlights this type of disease's rising age. In individuals with untreated anterior uveitis, there is a high risk of loss of vision and cataract, glaucoma or retinal edema. 

Based on distribution channel, the market is segmented into hospitals, ophthalmology clinics, ambulatory surgical centers, and others. Hospital pharmacies dominate the market in 2018 based on the distribution channel due to the availability of a wide range of options for treating eye inflammation in hospitals. Therefore, hospitals provide treatment and care for a large number of patients, rendering hospital pharmacies a leading group.

Regional segmentation includes the current and forecast demand for Asia Pacific, North America, Latin America, Europe, and Middle East & Africa with its further bifurcation into major countries. In 2018, North America led the market as a result of the growing prevalence of non-infectious uveitis in the United States. Furthermore, to promote regional development, advanced health care facilities and reimbursement policies are credited. Large numbers of drugs are commercially available in the United States, further enhancing the demand of the region.

Some of the players included in Uveitis Treatment market are Allergan, Inc., Bausch & Lomb Incorporated, Santen Pharmaceutical Co., Ltd, AbbVie Inc., Novartis AG, Eyegate Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Eyepoint pharmaceuticals Inc., and Alimera Sciences, Inc. amongst others.

The report segments the Uveitis Treatment market as follows:

Global Uveitis Treatment Market: Treatment type Segment Analysis

• Corticosteroids
• Immunosuppressant
• Monoclonal Antibodies
• Cycloplegic Agents
• Antibiotics
• Antivirals
• Antifungal
• Analgesics

Global Uveitis Treatment Market: Disease type Segment Analysis

• Anterior Uveitis
• Posterior Uveitis
• Intermediate Uveitis
• Panuveitis

Global Uveitis Treatment Market: Distribution Channel Segment Analysis

• Hospitals
• Ophthalmology Clinics
• Ambulatory Surgical Centers
• Others

Global Uveitis Treatment Market: Regional Segment Analysis

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com